Medco Announces Date for Second-Quarter 2009 Financial Results

FRANKLIN LAKES, N.J., June 30 /PRNewswire-FirstCall/ -- Medco Health
Solutions, Inc. (NYSE: MHS) plans to announce its second-quarter 2009
financial results in a press release before the market opens on Wednesday,
July 29, 2009.

Following the release, management will hold a conference call to review the
financial results, outlook and related matters at 8:30 a.m. ET.

To access the live conference call via telephone:
Dial in: (800) 949-5383 from inside the U.S., or (706) 679-3440 from outside
the U.S.

To access the live webcast:
Visit the Investor Relations section at www.medco.com/investor.

For a replay of the call:
A replay of the call will be available after the event on July 29, 2009
through August 13, 2009. Dial in: (800) 642-1687 from inside the U.S., or
(706) 645-9291 from outside the U.S. Please use passcode 15222258.

About Medco
Medco Health Solutions, Inc (NYSE: MHS) is a leading health care company,
serving the needs of more than 60 million people. Medco, the world's most
advanced pharmacy(R), provides clinically driven pharmacy services designed to
improve the quality of care and lower total health care costs for private and
public employers, health plans, labor unions and government agencies of all
sizes, and for individuals served by Medicare Part D Prescription Drug Plans.
Through its unique Medco Therapeutic Resource Centers(R) and the Accredo
Health Group, Medco's Specialty Pharmacy, the company is creating innovative
models for the care of patients with chronic and complex conditions. Medco is
a leader in the emerging field of personalized medicine and in applying
evidence-based protocols to elevate the practice of pharmacy - a key element
in reforming America's health care system. Medco is ranked number 45 on the
Fortune 500 list, with 2008 revenues of more than $51 billion. For more
information about Medco, go to http://www.medcohealth.com.

This press release contains "forward-looking statements" as that term is
defined in the Private Securities Litigation Reform Act of 1995. These
statements involve risks and uncertainties that may cause results to differ
materially from those set forth in the statements. No forward-looking
statement can be guaranteed, and actual results may differ materially from
those projected. We undertake no obligation to publicly update any
forward-looking statement, whether as a result of new information, future
events, or otherwise. Forward-looking statements in this press release should
be evaluated together with the risks and uncertainties that affect our
business, particularly those mentioned in the Risk Factors section of the
Company's Annual Report on Form 10-K and Quarterly Reports on Form 10-Q filed
with the Securities and Exchange Commission.

SOURCE Medco Health Solutions, Inc.

Investors: Mary Giordano, +1-201-269-5101, mary_giordano@medco.com; or Media:
Jennifer Luddy, +1-201-269-6402, jennifer_luddy@medco.com